{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:33Z","timestamp":1707524973490},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,13]]},"DOI":"10.7759\/cureus.37545","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T02:14:08Z","timestamp":1681438448000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Risk Factors for Death in Patients With Empyema and Active Malignancy"],"prefix":"10.7759","author":[{"given":"Moiz","family":"Salahuddin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunsoo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahara","family":"Saltijeral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Casal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Sabath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eben","family":"Cerrillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Nev\u00e1rez Tinoco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horiana","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.156406","article-title":"Emergence of parapneumonic empyema in the USA","volume":"66","author":"Grijalva CG","year":"2011","unstructured":"Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax. 2011, 66:663-8. 10.1136\/thx.2010.156406","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1558","article-title":"A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection","volume":"145","author":"Rahman NM","year":"2014","unstructured":"Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014, 145:848-55. 10.1378\/chest.13-1558","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.09.038","article-title":"Management of pleural space infections: a population-based analysis","volume":"133","author":"Farjah F","year":"2007","unstructured":"Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007, 133:346-51. 10.1016\/j.jtcvs.2006.09.038","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/975312","article-title":"Empyema: an increasing concern in Canada","volume":"15","author":"Finley C","year":"2008","unstructured":"Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J. 2008, 15:85-9. 10.1155\/2008\/975312","journal-title":"Can Respir J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201407-329OC","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery","volume":"11","author":"Piccolo F","year":"2014","unstructured":"Piccolo F, Pitman N, Bhatnagar R, et al.. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Ann Am Thorac Soc. 2014, 11:1419-25. 10.1513\/AnnalsATS.201407-329OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2019.06.008","article-title":"Polymicrobial etiology as a prognostic factor for empyema in addition to the renal, age, purulence, infection source, and dietary factors score","volume":"57","author":"Yamazaki A","year":"2019","unstructured":"Yamazaki A, Ito A, Ishida T, Washio Y. Polymicrobial etiology as a prognostic factor for empyema in addition to the renal, age, purulence, infection source, and dietary factors score. Respir Investig. 2019, 57:574-81. 10.1016\/j.resinv.2019.06.008","journal-title":"Respir Investig"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","unstructured":"American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005, 171:388-416. 10.1164\/rccm.200405-644ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00541-2019","article-title":"A systematic review of comorbidities and outcomes of adult patients with pleural infection","volume":"54","author":"Cargill TN","year":"2019","unstructured":"Cargill TN, Hassan M, Corcoran JP, et al.. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J. 2019, 54:10.1183\/13993003.00541-2019","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.4.285","article-title":"The clinical course and management of thoracic empyema","volume":"89","author":"Ferguson AD","year":"1996","unstructured":"Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996, 89:285-9. 10.1093\/qjmed\/89.4.285","journal-title":"QJM"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1912","article-title":"Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study","volume":"145","author":"S\u00f8gaard M","year":"2014","unstructured":"S\u00f8gaard M, Nielsen RB, N\u00f8rgaard M, Kornum JB, Sch\u00f8nheyder HC, Thomsen RW. Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study. Chest. 2014, 145:189-92. 10.1378\/chest.13-1912","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13395","article-title":"Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: a 6-year analysis","volume":"24","author":"Brims F","year":"2019","unstructured":"Brims F, Popowicz N, Rosenstengel A, et al.. Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: a 6-year analysis. Respirology. 2019, 24:171-8. 10.1111\/resp.13395","journal-title":"Respirology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.137000","article-title":"Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010","volume":"65 Suppl 2","author":"Davies HE","year":"2010","unstructured":"Davies HE, Davies RJ, Davies CW. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010, 65 Suppl 2:ii41-53. 10.1136\/thx.2010.137000","journal-title":"Thorax"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9903002","article-title":"Predictors of outcome and long-term survival in patients with pleural infection","volume":"160","author":"Davies CW","year":"1999","unstructured":"Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999, 160:1682-7. 10.1164\/ajrccm.160.5.9903002","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/imj.13087","article-title":"Pleural infection in a New Zealand centre: high incidence in Pacific people and RAPID score as a prognostic tool","volume":"46","author":"Wong D","year":"2016","unstructured":"Wong D, Yap E. Pleural infection in a New Zealand centre: high incidence in Pacific people and RAPID score as a prognostic tool. Intern Med J. 2016, 46:703-9. 10.1111\/imj.13087","journal-title":"Intern Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman NM","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al.. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011, 365:518-26. 10.1056\/NEJMoa1012740","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2019.05.090","article-title":"Outcomes of operative and nonoperative treatment of thoracic empyema: a population-based study","volume":"108","author":"Nayak R","year":"2019","unstructured":"Nayak R, Brogly SB, Lajkosz K, Lougheed MD, Petsikas D. Outcomes of operative and nonoperative treatment of thoracic empyema: a population-based study. Ann Thorac Surg. 2019, 108:1456-63. 10.1016\/j.athoracsur.2019.05.090","journal-title":"Ann Thorac Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin PC","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016, 133:601-9. 10.1161\/CIRCULATIONAHA.115.017719","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001940","article-title":"Blood culture and pleural fluid culture yields in pediatric empyema patients: a retrospective review, 1996-2016","volume":"37","author":"Stankey CT","year":"2018","unstructured":"Stankey CT, Spaulding AB, Doucette A, Hamre KE, Wheeler W, Pomputius WF, Kurachek S. Blood culture and pleural fluid culture yields in pediatric empyema patients: a retrospective review, 1996-2016. Pediatr Infect Dis J. 2018, 37:952-4. 10.1097\/INF.0000000000001940","journal-title":"Pediatr Infect Dis J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149124-clinical-risk-factors-for-death-in-patients-with-empyema-and-active-malignancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:44Z","timestamp":1707508724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149124-clinical-risk-factors-for-death-in-patients-with-empyema-and-active-malignancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.37545","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,13]]}}}